Intensive cyclic chemotherapy and autologous transplantation of peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer follow up at 10 years

Abstrakt

The main aim of our paper is to contribute to objectification of currently widely discussed results of overall survival (OS), disease free survival (DFS) and time from relapse to tumor progression (TTP) in women with breast cancer.